Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

2.

Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.

Mendelsohn J.

J Natl Cancer Inst Monogr. 1992;(13):125-31. Review.

PMID:
1389685
3.

The epidermal growth factor receptor as a target for cancer therapy.

Mendelsohn J.

Endocr Relat Cancer. 2001 Mar;8(1):3-9. Review.

4.

Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.

Mendelsohn J.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):889-92. Review.

PMID:
2285602
6.

Regulation of cell proliferation by epidermal growth factor.

Schlessinger J, Schreiber AB, Levi A, Lax I, Libermann T, Yarden Y.

CRC Crit Rev Biochem. 1983;14(2):93-111. Review.

PMID:
6301752
7.
8.

The role of erbB-2 and its ligands in growth control of malignant breast epithelium.

Lupu R, Dickson RB, Lippman ME.

Princess Takamatsu Symp. 1991;22:49-60. Review.

PMID:
1688228
9.

The EGF/TGF alpha receptor in skin.

King LE Jr, Gates RE, Stoscheck CM, Nanney LB.

J Invest Dermatol. 1990 Jun;94(6 Suppl):164S-170S. Review.

PMID:
2191051
10.

Ionic signal transduction in growth factor action.

De Laat SW, Moolenaar WH, Defize LH, Boonstra J, van der Saag PT.

Biochem Soc Symp. 1985;50:205-20. Review.

PMID:
3019351
11.

The EGF receptor system as a target for antitumor therapy.

Ennis BW, Lippman ME, Dickson RB.

Cancer Invest. 1991;9(5):553-62. Review.

PMID:
1933488
12.

Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.

Le Doussal JM, Barbet J, Delaage M.

Int J Cancer Suppl. 1992;7:58-62. Review.

PMID:
1428406
13.

Transforming growth factor beta regulation of cell proliferation.

Moses HL, Coffey RJ Jr, Leof EB, Lyons RM, Keski-Oja J.

J Cell Physiol Suppl. 1987;Suppl 5:1-7. Review.

PMID:
3316252
14.

Regulatory features of the epidermal growth factor receptor.

Gill GN, Santon JB, Bertics PJ.

J Cell Physiol Suppl. 1987;Suppl 5:35-41. Review.

PMID:
3316253
15.

111In/86Y-Labeled F(ab')2 fragment of panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Apr 30 [updated 2012 Jun 21].

17.

The EGF receptor: structure, regulation and potential role in malignancy.

Thompson DM, Gill GN.

Cancer Surv. 1985;4(4):767-88. Review.

PMID:
2824044
18.

Radioiodinated anti–TAG-72 CC49 (Fab’)2 antibody fragment.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2007 Nov 5 [updated 2008 Jan 9].

19.

F(ab')2 fragments versus intact antibody--an isodose comparison.

Humm JL, Chin LM, Macklis RM.

J Nucl Med. 1990 Jun;31(6):1045-7. Review. No abstract available.

20.

Gut hormones, growth and malignancy.

Baldwin GS, Whitehead RH.

Baillieres Clin Endocrinol Metab. 1994 Jan;8(1):185-214. Review.

PMID:
7907861

Supplemental Content

Support Center